tirzepatide and ckd Renal effects of GLP-1 receptor agonists in individuals with type 2 diabetes: seeds of a promising future | Endocrine tirzepatide and kidney damage Long-Term

People receiving the highest Tirzepatide 15 mg lost nearly 21% of their starting body weight on average

Melanin displays paramagnetic effects, leading to stable free radicals

Accelerating Into the Mainstream Consumer demand for peptide therapies has moved into mainstream channels

The lack of significant effects on renal outcomes in this population may be due to the relatively short duration of follow-up in some studies or the inclusion of patients with less severe renal impairment

Bottom line: While leg pain isnt a primary side effect, it is often a downstream result of the GI and metabolic changes the medication creates

Evidence suggests that this effect is not related solely to weight reduction and better glycaemic control